AtriCure to Participate in the Piper Sandler 36th Annual Healthcare Conference
The Market Lifts AtriCure, Inc. (NASDAQ:ATRC) Shares 28% But It Can Do More
US$42.67 - That's What Analysts Think AtriCure, Inc. (NASDAQ:ATRC) Is Worth After These Results
Are Investors Undervaluing AtriCure, Inc. (NASDAQ:ATRC) By 29%?
Earnings Call: AtriCure Reports Robust Growth, Raises Full-year Guidance
AtriCure | 10-Q: Q3 2024 Earnings Report
AtriCure Is Maintained at Overweight by JP Morgan
Snap Posts Upbeat Earnings, Joins Unisys, AtriCure, Garmin And Other Big Stocks Moving Higher On Wednesday
AtriCure Up Over 23%, on Pace for Largest Percent Increase Since June 2009 -- Data Talk
Q3 2024 AtriCure Inc Earnings Call
AtriCure Plans a Surgical Pulsed Field Ablation Play
UBS Maintains Buy on AtriCure, Raises Price Target to $40
A Quick Look at Today's Ratings for AtriCure(ATRC.US), With a Forecast Between $36 to $60
CalciMedica CALC Phase 2b Data; AtriCure ATRC Earnings
AtriCure Analyst Ratings
Express News | AtriCure Inc : Canaccord Genuity Raises Target Price to $53 From $49
AtriCure, Inc. (ATRC) Q3 2024 Earnings Call Transcript Summary
AtriCure, Inc. (ATRC) Q3 2024 Earnings Call Transcript
AtriCure (ATRC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
12 Health Care Stocks Moving In Tuesday's After-Market Session